Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Targeting pemphigus autoantibodies through their heavy-chain variable region genes.

Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Abstract Text:

    aimee s payneAimee S Payne,don l siegelDon L Siegel,john r stanleyJohn R Stanley,

    Pemphigus vulgaris (PV) is a potentially fatal blistering disease characterized by autoantibodies against cell surface adhesion proteins desmoglein (Dsg) 3 and Dsg1. Previous studies using phage display to clone Dsg-reactive monoclonal antibodies from a PV patient demonstrated that a limited number of antibody variable region genes encode the autoantibody repertoire, with different genes for pathogenic and non-pathogenic mAbs. Here, we investigated the feasibility of specific autoantibody targeting in pemphigus. We produced rabbit anti-idiotypic antibodies against two pathogenic and two non-pathogenic PV mAbs. Antisera inhibited binding of the immunizing mAb to Dsgs by ELISA as well as pathogenicity against cultured human keratinocytes. Antisera also inhibited other mAbs using the same variable region heavy chain (V(H)) genes, despite different light chains or somatic mutations. Additionally, peptide phage display identified peptide sequences that bound PV mAbs in a V(H)-specific manner. To evaluate the therapeutic potential of V(H) gene-targeted reagents, preimmune sera and antisera were used to adsorb pathogenic antibodies from PV sera. Pooled antisera significantly reduced pathogenic activity from the original PV patient's serum and bound pathogenic antibodies from two other PV sera, suggesting shared autoantibody V(H) gene usage among PV patients. Together, these data suggest novel V(H) gene-targeted approaches toward PV treatment.

    Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Publishing Authors By Initials

    as payneAS Payne,dl siegelDL Siegel,jr stanleyJR Stanley,

    For similar skin and connective tissue diseases: skin diseases: skin diseases, vesiculobullous: pemphigus research abstracts see: skin and connective tissue diseases: skin diseases: skin diseases, vesiculobullous: pemphigus research

    PUBMED ID PMID:

    MEDLINE DATE:

    Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of investigative dermatology

    VOLUME: 127

    Page Numbers: 1681-91

    Journal Abbreviation: J. Invest. Dermatol.

    ISSN: 1523-1747

    DAY: 29

    MONTH: 03

    YEAR: 2007

    Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 426720

    Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Keywords Mesh Terms:

    KEYWORDS: Pemphigus

    MESH TERMS: therapy

    Chemical & Substance for Abstract: Targeting pemphigus autoantibodies through their heavy-chain variable region genes. Information

    Substance Name: Immunoglobulin Variable Region

    Registry Number: 0

    Grant and Affiliation Information for Targeting pemphigus autoantibodies through their heavy-chain variable region genes.

    AFFILIATION: Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. paynea@mail.med.upenn.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAMS

    GRANT: T32-AR07465

    ACRONYM: AR

    MEDLINETA: J Invest Dermatol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Targeting pemphigus autoantibodies through their heavy-chain variable region genes Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News